Program Nomination Form: Executive Summary Name/Department of Principal Investigator: Target and Therapeutic Indication: Date of Submission (Month/day/year): The Right Information Requested and to be filled in from Principal Investigator (PI), WARF Therapeutics , or Consultant Target Tissue Safety Patients Commercial Potential Molecule (Modality)

The Right Target

The Right Target (continued)

The Right Tissue

The Right Tissue (continued)

The Right Safety

The Right Safety (continued)

The Right Patients

The Right Patients (continued)

The Right Commercial Potential

The Right Commercial Potential (continued)